Submit the Abstract

Abstract Eligibility Criteria

AUTHOR ELIGIBILITY:

·         Individuals may submit up to two regular abstracts as the first author.

·         Individuals may submit an unlimited number of Trials in Progress abstracts.

·         Individuals may serve as a co-author on an unlimited number of abstracts.

ABSTRACT ELIGIBILITY

·         All types of Neurologists, Board Directors, Young researches & Students, Educational institutions, Neurology Industrialist, Neurology organisations,  Professors, Neurology and neuroscience Researcher’s, Pharmacist, Neuropsychologist and Physicians are eligible for submission.

·         Abstract should address scientific questions, detail clinical observations, or contain primary scientific data.

·         Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown. 

·         Interim analysis of a prospective randomized clinical trial will be considered if it is performed as planned in the original protocol and is statistically valid.

·         Abstracts of clinically-related subjects should be combined into a single abstract. Please Note: Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts.

Submission Requirements

Provide your full name, academic degree(s), institution, address, and email address and recent photograph. You will receive all future correspondence from us regarding the status of your abstract. 

The selected abstracts will be published in Conference Proceedings.

Important Dates:

Abstract Submission Deadline: February 25, 2019

First Early Bird  Date: October 22, 2018

Speaker Presentations Sessions and Time limits:

Keynote Speech 40-45 Minutes

Workshop/Symposium 60 Minutes

Plenary Speech 20-25 Minutes

Poster Presentation 10-15 Minutes